Serotype specificity of vaccine-induced immunity to pertussis

N W Preston1, E J Carter

  • 1Department of Medical Microbiology, University Medical School, Manchester.

Insights

Pertussis epidemics in Britain were linked to reduced vaccine uptake. Current vaccines show varied efficacy against different pertussis serotypes, highlighting the need for broader protection.

Area of Science:

  • Immunology
  • Epidemiology
  • Vaccinology

Background:

  • Pertussis (whooping cough) epidemics occurred in Britain in the late 1970s and early 1980s.
  • These outbreaks followed a significant decline in pertussis vaccine uptake.
  • Pertussis is caused by the bacterium *Bordetella pertussis*, which has multiple serotypes.

Purpose of the Study:

  • To investigate the serotype distribution of *Bordetella pertussis* isolates during pertussis epidemics.
  • To compare the effectiveness of whole-cell pertussis vaccines against different serotypes.
  • To inform the development of future acellular pertussis vaccines.

Main Methods:

  • Analysis of *Bordetella pertussis* isolates from pertussis cases in Britain during epidemic periods.
  • Comparison of serotype prevalence in unvaccinated versus vaccinated children.
  • Evaluation of whole-cell vaccine efficacy based on existing data regarding serotype-specific protection.

Main Results:

  • Serotype 1,3 predominated during both major pertussis epidemics.
  • Serotypes 1,2 and 1,2,3 were significantly more prevalent in unvaccinated children (32%) compared to vaccinated children (10%).
  • Whole-cell vaccines demonstrated higher efficacy against serotypes 1,2 and 1,2,3 than against serotype 1,3.

Conclusions:

  • Pertussis vaccine effectiveness varies by serotype, with whole-cell vaccines being less protective against serotype 1,3.
  • Future acellular pertussis vaccines should include antigens for all prevalent serotypes.
  • Clinical trials must demonstrate efficacy against all three major pertussis serotypes to ensure comprehensive protection.

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
Vaccinations01:51

Vaccinations

Overview
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Active versus Passive Immunity01:31

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...